Measurement of Plasma-Derived Substance P: Biological, Methodological, and Statistical Considerations
Donald E. Campbell(Pennsylvania Hospital), Steven D. Douglas(Purdue University West Lafayette), Nancy B. Tustin(Children's Hospital of Philadelphia), Michelle DeSilvio(Newark Beth Israel Medical Center), Avital Cnaan(Children's Hospital of Philadelphia), R. Don Tustin(Children's Hospital of Philadelphia), Andrew A. Lackner(Tulane University), Nancy Raftery(Tulane University), Pyone P. Aye(Tulane University)
Cited by 32
Related Papers
Lymphocyte subsets in healthy children from birth through 18 years of age
|Journal of Allergy and Clinical Immunology|2003|828
ILAE Treatment Guidelines: Evidence‐based Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and Syndromes
|Epilepsia|2006|789
Updated <scp>ILAE</scp> evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes
|Epilepsia|2013|718
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Inhaled Nitric Oxide in Preterm Infants Undergoing Mechanical Ventilation
|New England Journal of Medicine|2006|487